logo
welcome
USA Today

USA Today

Diabetes patients worry about insulin shortages as Ozempic use skyrockets

USA Today
Summary
Nutrition label

73% Informative

Patients who depend on insulin have encountered shortages, delays and red tape from drug companies and pharmacies.

About 2 million Americans with Type 1 diabetes must take insulin to regulate their blood sugar because their bodies do not produce insulin.

About 38 million Americans have diabetes, the majority Type 2 .

Patients increasingly turn to drugs such as Ozempic and Mounjaro for weight loss.

In response to public pressure, manufacturers slashed insulin prices by 70% or more last year .

Companies have been questioned over the price of insulin in congressional hearings and investigations.

Advocates worried diabetes patients might not always be able to get the medication they need to survive.

GLP-1 diabetes and weight loss drugs tested their manufacturing capacity.

Novo Nordisk charges U.S. residents $ 969 a month for Ozempic, far more than what the drug costs in Canada or Europe .

CEO: "The world market for insulin is actually declining, so there's less demand" Smith: Diabetes patients especially those with Type 1 still need insulin.

VR Score

80

Informative language

83

Neutral language

55

Article tone

informal

Language

English

Language complexity

57

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

short-lived

External references

no external sources

Source diversity

no sources

Affiliate links

no affiliate links